Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
Citation: Boominathan, AntagomiR-based therapy for T2DM: MiRNA-27 promotes glucose intolerance and insulin resistance via down regulation of its target gene, 23/January/2015, 23.36, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org
Significance: This study suggests, for the first time, that MiRNA-27, by suppressing the expression of its target gene, it may promote glucose intolerance and insulin resistance. Thus, pharmacological formulations encompassing “miRNA-27 inhibitors“ may be used to inhibit glucose intolerance and insulin resistance
Amount: $ 300
Undisclosed information: How miRNA-27 inhibits glucoe intolerance and insulin resistance
Web: http://genomediscovery.org
Courtesy: When you cite drop us a line at info@genomediscovery.org